On October 19, 2022, Shandong Branden Medical Devices Co., Ltd. disclosed its prospectus (draft for declaration). The company plans to publicly issue no more than 20.52 million shares, accounting for no less than 25% of the total share capital after the issuance, with the final number subject to approval by the China Securities Regulatory Commission. (National Business Daily)

